NM_145239.3:c.971dupG
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_145239.3(PRRT2):c.971dupG(p.Val325SerfsTer16) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,456,206 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_145239.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRRT2 | ENST00000358758.12 | c.971dupG | p.Val325SerfsTer16 | frameshift_variant | Exon 3 of 4 | 1 | NM_145239.3 | ENSP00000351608.7 | ||
ENSG00000280893 | ENST00000609618.2 | n.960dupG | non_coding_transcript_exon_variant | Exon 3 of 6 | 5 | ENSP00000476774.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1456206Hom.: 0 Cov.: 35 AF XY: 0.00000138 AC XY: 1AN XY: 724306
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Episodic kinesigenic dyskinesia 1 Pathogenic:1
- -
Seizures, benign familial infantile, 2 Pathogenic:1
- -
Episodic kinesigenic dyskinesia Pathogenic:1
This premature translational stop signal has been observed in individual(s) with paroxysmal kinesigenic dyskinesia (PMID: 32392383). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Val325Serfs*16) in the PRRT2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 16 amino acid(s) of the PRRT2 protein. For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PRRT2 protein in which other variant(s) (p.Ile327Met) have been determined to be pathogenic (PMID: 2131349, 23496026, 24609974, 24886244). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 871891). This variant is also known as c.971_972insG. -
PRRT2-related disorder Pathogenic:1
The PRRT2 c.971dupG variant is predicted to result in a frameshift and premature protein termination (p.Val325Serfs*15). This variant has been reported in an individual with paroxysmal kinesigenic dyskinesia (Huang et al. 2020. PubMed ID: 32392383) and it has also been reported in an individual with infantile seizures (Table 2, Liu et al. 2021. PubMed ID: 34298581). This variant is reported in 0.00091% of alleles in individuals of European (non-Finnish) descent in gnomAD. Frameshift variants in PRRT2 are expected to be pathogenic. This variant is interpreted as pathogenic. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at